Setback For AbbVie’s Humira As English Court Decision Clears Way For Biosimilars

Samsung Bioepis and Fujifilm Kyowa Kirin Biologics have won a patent battle that should allow them to launch their biosimilar versions of AbbVie’s Humira in the UK and may also have implications for other companies wanting to clear away legal uncertainties.